|
EQUBITS Licenses Foresight to Novartis and Johnson and Johnson
Palo Alto, CA - New customers validate EQUBITS ForesightTM leading position in predictive modeling industry.
EQUBITS announces first customers of their flagship product, EQUBITS Foresight. Customers include (but not limited to) Novartis and Johnson and Johnson PRD. "After extensive testing and validation, customers are flocking to EQUBITS Foresight as an easy-to-use software solution for their data mining problems. Our customers expect a lot from new software and, as a result, evaluated and tested Equbits Foresight rigorously. By outperforming existing methods in customer evaluations, EQUBITS has established itself as a best in class, accurate, interpretable predictive modeling solution provider," says Ravi Mallela, VP of Marketing, EQUBITS LLC.
EQUBITS Foresight is being used to solve complex predictive modeling problems in the High Throughput Screening and ADME-Tox environments. By applying EQUBITS Foresight to challenging predictive modeling problems, customers are generating more accurate, interpretable results. "Equbits provides customers with data mining solutions that combine the accuracy of non-linear modeling with a level of interpretability provided by linear models," says Dr. Mallela.
EQUBITS is a market leader in providing easy to use, accurate, interpretable and automated Support Vector Machine (SVM) based predictive intelligence and analytics software. EQUBITS Foresight is an easy to use desktop and enterprise predictive intelligence and analytics software built on SVM technology that provides high predictive accuracy, interpretation and discovery.
For more information, contact EQUBITS at 510-593-3223.
About Equbits
Equbits LLC (www.equbits.com) provides software that helps scientists at pharmaceutical companies accelerate lead optimization. Equbits is a leading provider of state-of-the-art machine learning techniques for pharmaceutical scientists. Equbits applies advanced machine learning techniques including Support Vector Machines to QSAR (Quantitative Structure Activity Relationship) predictive modeling in an easy to use, intuitive software application geared towards HTS (High Throughput Screening) and ADME chemists. Founded by experts in the fields of machine learning, chemistry and software development, Equbits makes drug discovery possible with first-in-class computational applications that provide the most accurate, interpretable results.
For more information on Equbits LLC, please contact:
Name: Ravi Mallela
Phone: +1 510 593 3223
E-mail: ravi@equbits.com
|
|
|
Equbits brings together expertise from the rational drug design arena, software applications development industry, and the field of machine learning theory.
New technologies were not entering the biopharmaceutical industry at a pace that met scientist's needs.
The industry has been inundated with products yet most software applications remain behind the curve on machine learning side. The latest methods were not being applied to the domain.
Equbits was formed to bring the latest technologies to scientists in an easy to use software application that makes results easy to interpret and analyze.
|
|
|
Case Studies
News & Events
